Discover 1,072 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,072
Nectero EAST System Clinical Study
for
Abdominal Aortic Aneurysm
Location: Boston MA, Worcester MA, Philadelphia PA, Bethlehem PA,
Sponsor: Nectero Medical, Inc.
Sex: All
Age: 21 - 70+
Code: NCT06001918
Phase2, Phase3, Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Raleigh NC, Tampa FL, Detroit MI, St Louis MO,
Sponsor: MOMA Therapeutics
Sex: All
Age: 18+
Code: NCT06974110
Phase1, Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Wynnewood PA, Norfolk VA, Columbia MD, Salem VA,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07011576
Phase2, Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
for
Solid Cancer
Location: New Haven CT, Lake Success NY, New York NY, Teaneck NJ,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06161025
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Lubbock TX, Spokane WA, Richland WA, Everett WA,
Sponsor: Swedish Medical Center
Sex: All
Age: 18+
Code: NCT07108660
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: JenaValve Technology, Inc.
Sex: All
Age: 0+
Code: NCT06608823
Recruiting
Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles
for
Muscle Tone, Muscle Strength
Location: Eugene OR
Sponsor: Sofwave Medical LTD
Sex: All
Age: 25 - 60
Code: NCT07094971
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: St. John's, Westbrook ME, Boston MA, Quebec, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions
for
Child Abuse, Decision Making, Child Welfare,
Location: Eugene OR
Sponsor: Chestnut Health Systems
Sex: All
Age: 18+
Code: NCT06375551
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase2, Phase3, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase3, Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Boston MA, The Bronx NY, New York NY, Hershey PA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06731478
Phase3, Recruiting
TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD
for
Parkinson Disease,
Location: Tempe AZ, Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 50 - 70+
Code: NCT06815302
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Location: Springfield MA, Westbury NY, New York NY, Bloomfield NJ,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT07064759
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
for
Frontotemporal Dementia, Caregiver Burden,
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18 - 70+
Code: NCT06613204
Recruiting
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT